Rise In Medical Costs

By Yaser Anwar, CSC of Equity Investment Ideas

USA Today reports, Brand-name drug prices jumped nearly 4% the first three months of the year, raising costs for taxpayers subsidizing the Medicare drug program and for some people participating in the program, AARP said Tuesday.

AARP, an advocacy group for senior citizens, said the quarterly increase was the largest since 2000. Pharmaceutical companies say the increases were in line with overall medical inflation.

http://www.equityinvestmentideas.blogspot.com/